EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects and microbiota changes following oral lyophilized fecal microbiota transplantation in children with autism spectrum disorder

Youran Li, Pei Xiao, Rong Cao, Jun Le, Qiao Xu, Fangfei Xiao, Lin Ye, Xufei Wang, Yizhong Wang, Ting Zhang

Frontiers in Pediatrics · 09.05.2024 · 12

DOI: 10.3389/fped.2024.1369823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 09.05.2024. Verfasst von Youran Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Nutrition, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, …. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose Autism spectrum disorder (ASD) is a group of heterogeneous neurodevelopmental disorders that is characterized by core features in social communication impairment and restricted, repetitive sensory-motor behaviors. This study aimed to further investigate the utilization of fecal microbiota transplantation (FMT) in children with ASD, both with and without gastrointestinal (GI) symptoms, evaluate the effect of FMT and analyze the alterations in bacterial and fungal composition within the gut microbiota.

Methods

A total of 38 children diagnosed with ASD participated in the study and underwent oral lyophilized FMT treatment. The dosage of the FMT treatment was determined based on a ratio of 1 g of donor stool per 1 kg of recipient body weight, with a frequency of once every 4 weeks for a total of 12 weeks. In addition, 30 healthy controls (HC) were included in the analysis. The clinical efficacy of FMT was evaluated, while the composition of fecal bacteria and fungi was determined using 16S rRNA and ITS gene sequencing methods.

Results

Median age of the 38 children with ASD was 7 years. Among these children, 84.2% (32 of 38) were boys and 81.6% (31 of 38) exhibited GI symptoms, with indigestion, constipation and diarrhea being the most common symptoms. Sample collections and assessments were conducted at baseline (week 0), post-treatment (week 12) and follow-up (week 20). At the end of the follow-up phase after FMT treatment, the autism behavior checklist (ABC) scores decreased by 23% from baseline, and there was a 10% reduction in scores on the childhood autism rating scale (CARS), a 6% reduction in scores on the social responsiveness scale (SRS) and a 10% reduction in scores on the sleep disturbance scale for children (SDSC). In addition, short-term adverse events observed included vomiting and fever in 2 participants, which were self-limiting and resolved within 24 h, and no long-term adverse events were observed. Although there was no significant difference in alpha and beta diversity in children with ASD before and after FMT therapy, the FMT treatment resulted in alterations in the relative abundances of various bacterial and fungal genera in the samples of ASD patients. Comparisons between children with ASD and healthy controls (HC) revealed statistically significant differences in microbial abundance before and after FMT. Blautia , Sellimonas , Saccharomycopsis and Cystobasidium were more abundant in children with ASD than in HC, while Dorea were less abundant. After FMT treatment, levels of Blautia, Sellimonas , Saccharomycopsis and Cystobasidium decreased, while levels of Dorea increased. Moreover, the increased abundances of Fusicatenibacter, Erysipelotrichaceae_UCG-003, Saccharomyces, Rhodotorula, Cutaneotrichosporon and Zygosaccharomyces were negatively correlated with the scores of ASD core symptoms.

Conclusions

Oral lyophilized FMT could improve GI and ASD related symptoms, as well as sleep disturbances, and alter the gut bacterial and fungal microbiota composition in children with ASD. Clinical Trial Registration Chinese Clinical Trial Registry, ChiCTR2200055943. Registered 28 January 2022, www.chictr.org.cn .

Schlagwörter

Stichwörter der Autor:innen

autism spectrum disorderchildrenfecal microbiota transplantationgut microbiotatreatment

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology and Nutrition, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Institute of Pediatric Infection, Immunity and Critical Care Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Zitieren

APA

Li, Y., Xiao, P., Cao, R., Le, J., Xu, Q., Xiao, F., Ye, L., Wang, X., Wang, Y., & Zhang, T. (2024). Effects and microbiota changes following oral lyophilized fecal microbiota transplantation in children with autism spectrum disorder. Frontiers in Pediatrics, 12. https://doi.org/10.3389/fped.2024.1369823

Vancouver

Li Y, Xiao P, Cao R, Le J, Xu Q, Xiao F, et al. Effects and microbiota changes following oral lyophilized fecal microbiota transplantation in children with autism spectrum disorder. Frontiers in Pediatrics. 2024;12. doi:10.3389/fped.2024.1369823

BibTeX
@article{Li2024,
  author = {Li, Youran and Xiao, Pei and Cao, Rong and Le, Jun and Xu, Qiao and Xiao, Fangfei and Ye, Lin and Wang, Xufei and Wang, Yizhong and Zhang, Ting},
  title = {Effects and microbiota changes following oral lyophilized fecal microbiota transplantation in children with autism spectrum disorder},
  journal = {Frontiers in Pediatrics},
  year = {2024},
  volume = {12},
  doi = {10.3389/fped.2024.1369823}
}
Kostenlos starten →